Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




New Hemodialysis Catheter Maintains Long-Term Patency

By HospiMedica International staff writers
Posted on 27 Apr 2021
An innovative hemodialysis catheter with a unique lumen design can maintain primary patency rates for up to 180 days. More...


The BD (Franklin Lakes, NJ, USA) Pristine Long-Term 15.5F hemodialysis catheter boasts a side-hole free symmetric Y-Tip distal lumen, which is aimed to minimize thrombus adhesion (a problem commonly associated with side-hole catheters), facilitate blood clot aspiration prior to hemodialysis, and minimize recirculation rates in both forward and reverse flows. In a prospective feasibility study, which followed 45 patients who received the Pristine Catheter for six months, all catheters were patent at 60-days, and 90.9% remained patent at 180-days post procedure.

“The BD Pristine Catheter adds to our diversified portfolio of products in support of clinicians who care for patients with end stage kidney disease (ESKD) who require hemodialysis,” said Padraic O'Brien, worldwide president of peripheral intervention at BD. “This exciting technology is highly complementary to our current ESKD portfolio, and will enable us to offer a differentiated product that can help to improve the patient experience.”

“A majority of hemodialysis patients in the United States start their treatment with a catheter, and many of those catheter-dependent patients will suffer a catheter-related complication at some point during treatment, which can adversely impact the patient and create additional healthcare system costs,” said Michael Tal, MD, founder of Pristine Access Technologies (Israel), and inventor of the Pristine Catheter. “The Pristine Catheter was designed with hemodialysis patients in mind and to help address some of these concerns.”

While an arteriovenous fistula (AVF) remains the preferred access option for patients on hemodialysis therapy, these often can take four months or longer to mature, and a catheter is often required during this time period; but more than 40% of such patients develop a venous obstruction. Many patients, in fact, prefer a catheter over an AVF, for reasons that include inadequate preparation for dialysis, phobia or avoidance of surgery, or fear of needles (since the connection to the dialysis machine via a catheter does not require needles).

Related Links:
BD


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Medical Monitor
VITALMAX 4100SL
Imaging Table
Stille imagiQ2
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.